These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 28855589)
21. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
23. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma. Zhang Y; Zhang D; Jiang J; Dong L Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280 [TBL] [Abstract][Full Text] [Related]
24. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764 [TBL] [Abstract][Full Text] [Related]
25. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756 [TBL] [Abstract][Full Text] [Related]
26. MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer. Li T; Deng L; He X; Jiang G; Hu F; Ye S; You Y; Duanmu J; Dai H; Huang G; Tang C; Lei X Cancer Manag Res; 2019; 11():9353-9369. PubMed ID: 31807065 [TBL] [Abstract][Full Text] [Related]
27. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition. Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787 [TBL] [Abstract][Full Text] [Related]
30. microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma. Liu X; Yang L; Tu J; Cai W; Zhang M; Shou Z; Yao Y; Xu Q Oncotarget; 2017 Oct; 8(50):87737-87749. PubMed ID: 29152116 [TBL] [Abstract][Full Text] [Related]
31. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma. Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734 [TBL] [Abstract][Full Text] [Related]
32. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related]
34. Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer. Tong W; Sun D; Wang Q; Suo J Cell Biochem Biophys; 2015 Jun; 72(2):453-9. PubMed ID: 25567655 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
38. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
39. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. Hou KZ; Fu ZQ; Gong H World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462 [TBL] [Abstract][Full Text] [Related]
40. Lamp2 inhibits epithelial-mesenchymal transition by suppressing Snail expression in HCC. Zheng H; Yang Y; Ye C; Li PP; Wang ZG; Xing H; Ren H; Zhou WP Oncotarget; 2018 Jul; 9(54):30240-30252. PubMed ID: 30100986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]